Biojo Sciences

Biojo Sciences is a global portfolio biopharmaceutical company developing novel clinical-stage therapies that improve patient and family lives. Our approach offers an efficient development process by finding and delivering innovative clinical-stage biotechnologies through effective operations and an NRDO, non-research development only model. We invest in bringing early clinical-stage drug assets to commercialization. Our members have rich industry knowledge in the latest science, regulatory pathways, and business strategies.